Foster common approaches between People’s Republic of China and the European Union on Personalised Medicine research, development, innovation and policies
We are happy to announce that our “Scoping Paper: Review on health research and innovation priorities in [...]
"Get to know the European and Chinese landscape in Personalised Medicine-biobanking with special focus on the common [...]
IC2PerMed's article "“Integrating China in the International Consortium for Personalized Medicine”: The Coordination and Support Action to [...]
IC2PerMed at a glance
Supporting International collaboration for the development of Personalised Medicine
The International Consortium for Personalised Medicine (ICPerMed), umbrella initiative of IC2PerMed, aims at initiating and supporting communication and exchange on Personalised Medicine (PM) for aligning national agendas on research and funding activities. It brings together representatives of funding agencies and authorities from 29 countries and expands for increasing PM developments’ synergies at international level.
IC2PerMed project’s core objective is to build upon collaborative developments of Chinese and European experts on PM for elaborating a common strategy, enabling Chinese institutions to join the ICPerMed consortium. The 3 Expert Working Groups will set the path for a common approach of PM research, innovation, development and implementation over the project duration.